Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option

As on 06 Jun 2025

logo

Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option

Equity

NAV

565.58

CAGR (3 Years)

25.53%

AUM (Cr)

8,259.60

Risk

Very High Risk

About Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option

The primary investment objective of the Scheme is to generate consistent returns by investing in equity / equity related or fixed income securities of Pharma and other associated companies

Breakdown of this Fund

logo
Debt Others
0.81%
logo
Healthcare
38.36%
logo
Pharmaceuticals
112.65%
logo
Retail
6.95%

Market Capitalization

Get your FAQs right

What kind of returns does Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option provide?

plus

How much expense ratio is charged by Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option?

plus

What is the AUM of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option?

plus

What is the NAV of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option?

plus

What is the PE and PB ratio of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option?

plus

What is the exit load of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option?

plus

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions